SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3
Jeddidiah W. D. Griffin
Topics & Concepts
ProteasesProteaseProtease inhibitor (pharmacology)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusBiologyVirologyChemistryEnzymeCoronavirus disease 2019 (COVID-19)VirusBiochemistryViral loadMedicineInfectious disease (medical specialty)DiseasePathologyAntiretroviral therapyComputational Drug Discovery MethodsProtein Structure and DynamicsSARS-CoV-2 and COVID-19 Research